Nervonik closes $52.5m Series B funding to advance PNS system
Summary
Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system.
Description
Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source